4591 - 4600 of 9140 Results
Title
Year
-
OPENTitle: Cocaine and desipramine elicit distinct striatal noradrenergic and behavioral responses in selectively bred obesity-resistant and obesity-prone ratsJournal Name: Behavioural Brain ResearchPublisher: Elsevier BVVol: 346Issue #:Start Page: 137End Page: 143Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bbr.2017.11.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5860948Citation Count: 4
-
OPENTitle: Grey matter abnormalities are associated only with severe cognitive decline in early stages of Parkinson's diseaseJournal Name: CortexPublisher: Elsevier BVVol: 123Issue #:Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.cortex.2019.09.015Best OA location URL: https://cris.maastrichtuniversity.nl/en/publications/226efa6a-7701-420c-935c-2c284c758e52Citation Count: 17
-
OPENTitle: Shortening the SWAL-QOL: Is it possible to create a valid short form?Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 148Issue #:Start Page: 108362End Page: 108362Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2026.108362Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC13225615/Citation Count: 0
- Tandem Mass Spectrometry Multiplex Analysis of Glucosylceramide and Galactosylceramide Isoforms in Brain Tissues at Different Stages of Parkinson Disease2016RESTRICTEDTitle: Tandem Mass Spectrometry Multiplex Analysis of Glucosylceramide and Galactosylceramide Isoforms in Brain Tissues at Different Stages of Parkinson DiseaseJournal Name: Analytical ChemistryPublisher: American Chemical Society (ACS)Vol: 88Issue #: 3Start Page: 1856End Page: 1863Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.analchem.5b04227Citation Count: 83
-
OPENTitle: Identification of a nanomolar affinity α-synuclein fibril imaging probe by ultra-high throughput in silico screeningJournal Name: Chemical SciencePublisher: Royal Society of Chemistry (RSC)Vol: 11Issue #: 47Start Page: 12746End Page: 12754Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1039/d0sc02159hBest OA location URL: https://pubs.rsc.org/en/content/articlepdf/2020/sc/d0sc02159hCitation Count: 58
-
OPENTitle: Cerebellar contributions to cognitive deterioration in Parkinson's disease: Insights from multi-omics and longitudinal dataJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 219Issue #:Start Page: 107275End Page: 107275Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2026.107275Best OA location URL: https://doi.org/10.1016/j.nbd.2026.107275Citation Count: 0
- Investigating Simultaneity for Deep Learning–Enhanced Actual Ultra-Low-Dose Amyloid PET/MR Imaging2022OPENTitle: Investigating Simultaneity for Deep Learning–Enhanced Actual Ultra-Low-Dose Amyloid PET/MR ImagingJournal Name: American Journal of NeuroradiologyPublisher: American Society of Neuroradiology (ASNR)Vol: 43Issue #: 3Start Page: 354End Page: 360Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3174/ajnr.a7410Best OA location URL: https://www.ajnr.org/content/ajnr/43/3/354.full.pdfCitation Count: 7
- Oral Inosine Persistently Elevates Plasma antioxidant capacity in Parkinson's disease2016RESTRICTEDTitle: Oral Inosine Persistently Elevates Plasma antioxidant capacity in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 3Start Page: 417End Page: 421Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26483Citation Count: 43
-
OPENTitle: A Fixable Fluorescence‐Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed CellsJournal Name: Angewandte ChemiePublisher: WileyVol: 135Issue #: 40Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ange.202309306Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ange.202309306Citation Count: 1
- Diverse paths of phenotypic evolution in functional movement disorders: A longitudinal perspective2025RESTRICTEDTitle: Diverse paths of phenotypic evolution in functional movement disorders: A longitudinal perspectiveJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 144Issue #:Start Page: 108059End Page: 108059Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108059Citation Count: 1